Top Markets
Coin of the day
Crescent Biopharma, Inc. Crescent Biopharma, Inc.

Crescent Biopharma, Inc.

CBIO
Rang in Aktien #11764
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and... Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Aktienkurs
$17.81
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$661.63M
Veränderung (1 Tag)
0.30%
Veränderung (1 Jahr)
23.70%
Land
US
Handel Crescent Biopharma, Inc. (CBIO)

Kategorie

Kursverlauf für Crescent Biopharma, Inc. (CBIO)
Höchster Schlusskurs: $17.05 am 2026-08-01

Niedrigster Schlusskurs: $975.40 am 2014-01-01
Kursverlauf der Aktie von Crescent Biopharma, Inc. von 2014 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 13.59%
2025 -50.14%
2024 -86.89%
2023 -14.20%
2022 48.19%
2021 -58.54%
2020 -34.68%
2019 -42.59%
2018 -36.34%
2017 160.24%
2016 -6.70%
2015 -23.24%
2014 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH